XML 20 R10.htm IDEA: XBRL DOCUMENT v3.21.1
Revenue
 3 Months Ended
Mar. 31, 2021
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
Disaggregation of revenue
The following table represents Health Catalyst’s revenue disaggregated by type of arrangement (in thousands):
Three Months Ended March 31,
20212020
(unaudited)
Recurring technology$33,567 $24,699 
One-time technology (i.e., perpetual license)272 — 
Professional services22,007 20,417 
Total revenue$55,846 $45,116 
For the three months ended March 31, 2021 and 2020, 99.9% and 99.9%, respectively, of revenue was related to contracts with customers located in the United States.
Deferred Revenue and Performance Obligations
Deferred revenue includes advance customer payments and billings in excess of revenue recognized. For the three months ended March 31, 2021 and 2020, 42% and 33%, respectively, of the revenue recognized was included in deferred revenue at the beginning of the period.
Transaction price allocated to the remaining performance obligations
Most of our technology and professional services contracts have up to a three-year term, of which the vast majority are terminable after one year upon 90 days’ notice. For arrangements that do not allow the customer to cancel within one year or less, we expect to recognize $79.6 million of revenue on unsatisfied performance obligations as of March 31, 2021. We expect to recognize approximately 75% of the remaining performance obligations over the next 24 months, with the balance recognized thereafter.